FindTrial
Sign In

Randomised controlled trial of maintaining low serum ferritin levels in patients receiving darbepoetin (Aranesp®)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN89787518
Enrollment
Unknown
Registered
2003-09-12
Start date
2002-11-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Haemodialysis Surgery

Interventions

Randomised controlled trial. Random allocation to: 1. Maintenance of normal ferritin 2. Maintenance of elevated ferritin (standard therapy)

Sponsors

Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients will be drawn from the population of haemodialysis patients attending Leeds General Infirmary renal unit.

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

MeasureTime frame
Haemoglobin (g/dl), Darbepoetin (ug/kg/week), Serum Ferritin, Iron Dose (mg/kg/week). Transferrin saturation percentage. C-reactive protein.—

Secondary

MeasureTime frame
Not provided at time of registration—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026